Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Clinical Trial of the Safety and Efficacy of the Medical Device "Bone Substitute Based on Octacalcium Phosphate and Biologically Active Nucleic Acids for Bone Tissue Regeneration" (Nucleostim-VEGF)

NCT03076138 is registered in ClinicalTrials.gov with Histograft Co., Ltd. as lead sponsor.

NCT NCT03076138
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03076138 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Clinical Trial of the Safety and Efficacy of the Medical Device "Bone Substitute Based on Octacalcium Phosphate and Biologically Active Nucleic Acids for Bone Tissue Regeneration" (Nucleostim-VEGF)
Lead sponsor
Histograft Co., Ltd.
Phase
Not applicable
Overall status
Completed
Start date
March 6, 2017
Completion date
December 14, 2018
Enrollment
20 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

bone atrophy, bone cysts, bone deformity, bone fracture, bone loss, tooth loss